Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Declaring Victory: How FDA Releases REMS

This article was originally published in RPM Report

Executive Summary

There is a new category of FDA action letter: a REMS release. Dozens of sponsors of “MedGuide-only” REMS received them after an FDA policy change. But now, FDA is issuing them regularly to sponsors whose communication plans have met their goals – or at least run their course.


Related Content

FDAAA Fading? REMS Use Continues To Decline As Drug Safety Law Matures
REMS Modification Studies Could Use Foreign Markets As Controls
FDA Panel To Weigh Unmet Need Vs. Liver Injury With Samsca Kidney Indication
Everything REMS Under The Sun: FDA Lays Out Ambitious PDUFA V Meeting Agenda
FDAAA Impact Analysis (Year 5): The REMS Paradox
Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ
Allergan's Botox Off-Label Promotion Suit Raises Questions, But Why Would Wall Street Care?
Waking Up to REMS (Part 3): Redefining Marketing
Class REMS For Botulinum Toxin Products Warns Against Interchangeabilty
FDAAA Pays Off: Drug Safety Controls Bring Immediate Returns to Sponsors


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts